Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Schmidt

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
The Journal of Biological Chemistry|June 16, 2025
Characterization of the activity of KTX-1001, a small molecule inhibitor of multiple myeloma SET domain using surface plasmon resonanceChad A Lewis, Charles Schmidt, Lisa Beebe, et al.
Einstein (Sao Paulo, Brazil)|January 24, 2019
Leadership potential of physicians in a public teaching hospital in the city of São PauloAlexandre Fioranelli, Charles Schmidt, Nelson Wolosker, et al.
Nature Biotechnology|July 13, 2016
Data mining differential clinical outcomes associated with drug regimens using adverse event reporting dataMayur Sarangdhar, Scott Tabar, Charles Schmidt, et al.
Clinics (Sao Paulo, Brazil)|October 4, 2018
Academic health centers: integration of clinical research with healthcare and education. Comments on a workshopRoberto Jun Arai, Irene de Lourdes Noronha, José Carlos Nicolau, et al.
Leukemia & Lymphoma|December 19, 2017
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cellsZaw Min Oo, Anuradha Illendula, Jolanta Grembecka, et al.
Ebiomedicine|July 19, 2016
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven CancersAnuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Ebiomedicine|November 7, 2017
Corrigendum to: "Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers" [EBioMedicine 8 (2016) 117-131]Anuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The Journal of Biological Chemistry|June 16, 2025
Characterization of the activity of KTX-1001, a small molecule inhibitor of multiple myeloma SET domain using surface plasmon resonanceChad A Lewis, Charles Schmidt, Lisa Beebe, et al.
Einstein (Sao Paulo, Brazil)|January 24, 2019
Leadership potential of physicians in a public teaching hospital in the city of São PauloAlexandre Fioranelli, Charles Schmidt, Nelson Wolosker, et al.
Nature Biotechnology|July 13, 2016
Data mining differential clinical outcomes associated with drug regimens using adverse event reporting dataMayur Sarangdhar, Scott Tabar, Charles Schmidt, et al.
Clinics (Sao Paulo, Brazil)|October 4, 2018
Academic health centers: integration of clinical research with healthcare and education. Comments on a workshopRoberto Jun Arai, Irene de Lourdes Noronha, José Carlos Nicolau, et al.
Leukemia & Lymphoma|December 19, 2017
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cellsZaw Min Oo, Anuradha Illendula, Jolanta Grembecka, et al.
Ebiomedicine|July 19, 2016
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven CancersAnuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Ebiomedicine|November 7, 2017
Corrigendum to: "Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers" [EBioMedicine 8 (2016) 117-131]Anuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Pageof 9